Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001809104-25-000213
Filing Date
2025-07-07
Accepted
2025-07-07 17:12:54
Documents
1
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751922767.html 4  
1 FORM 4 wk-form4_1751922767.xml 4 3454
  Complete submission text file 0001809104-25-000213.txt   5116
Mailing Address C/O NMG BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Nolan Mangini Siobhan (Reporting) CIK: 0001679464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39299 | Film No.: 251108842

Mailing Address 4 OVERLOOK POINT LINCOLNSHIRE IL 60069
Business Address 4 OVERLOOK POINT LINCOLNSHIRE IL 60069 (702) 323-7330
Alight, Inc. / Delaware (Issuer) CIK: 0001809104 (see all company filings)

EIN.: 850545098 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)